REGN
Regeneron Pharmaceuticals Inc.
$759.44
▼ -0.42%
−$3.19
NASDAQ · Healthcare · Biotechnology
· price updated 9h ago
Regeneron Pharmaceuticals Inc.
REGN · NASDAQ · Healthcare · Biotechnology · price updated 9h ago
$759.44
▼ -0.42% · −$3.19 today
AI research · $759.44
Track REGN for continuous AI research
price position
Where REGN sits now
52-week range
Low$541.00
High$821.11
Today $759.44
RSI (14)
71.5Overbought
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$8.0B
Total debt$2.7B
Net cash after debt$5.3B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 34% below Sector avg · favorable
12.58x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
4.90x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
20.25x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
13.96x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
13.5%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
14.0%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.09x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
3.34x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How REGN compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $79.94B | 18.9 | +9.3% | 64 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Regeneron Pharmaceuticals Inc. (REGN) stock
Regeneron Pharmaceuticals Inc. tracked in the US core universe. REGN was -0.4% in the latest available session at $759.44. Its reported market value was $79.94B with a trailing P/E of 18.9. Latest reported revenue was $15.54B, changing +9.3% year over year, with $4.33B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $759.44
- Day change
- -0.4%
- Market cap
- $79.94B
- P/E (TTM)
- 18.9
- Revenue growth
- +9.3%
- Industry
- Biotechnology